Herein, we demonstrate a new role played by screen hit BCL6 in paclitaxel resistance in breast cancer and reveal associations with expression of some of the screen hits and breast cancer patient response to chemotherapy treatment that includes paclitaxel. Here, BCL6 is linked to breast carcinoma.